000 | 01027 a2200289 4500 | ||
---|---|---|---|
005 | 20250514170819.0 | ||
264 | 0 | _c20040220 | |
008 | 200402s 0 0 eng d | ||
022 | _a1533-4406 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchillaci, Giuseppe | |
245 | 0 | 0 |
_aXimelagatran versus warfarin after total knee replacement. _h[electronic resource] |
260 |
_bThe New England journal of medicine _cFeb 2004 |
||
300 |
_a616-7; author reply 616-7 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
650 | 0 | 4 | _aArthroplasty, Replacement, Knee |
650 | 0 | 4 |
_aAzetidines _xtherapeutic use |
650 | 0 | 4 | _aBenzylamines |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Normalized Ratio |
650 | 0 | 4 |
_aThromboembolism _xprevention & control |
650 | 0 | 4 |
_aWarfarin _xtherapeutic use |
700 | 1 | _aPasqualini, Leonella | |
700 | 1 | _aMannarino, Elmo | |
773 | 0 |
_tThe New England journal of medicine _gvol. 350 _gno. 6 _gp. 616-7; author reply 616-7 |
|
999 |
_c14491499 _d14491499 |